XBI Biotech sector
Company Analysis
Latest News
Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
The biotechnology sector is trading higher, driven by a significant collaboration between Boehringer Ingelheim and AI-powered drug discovery company...
🟢 XBI is trading 3.38% up today on stronger biotech R&D demand
XBI is trading 3.38% up now at $159.39 after improving pharmaceutical and biotech R&D demand, a healthier funding environment, and renewed M&A optimism. -...
Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
The biotechnology sector, as measured by the XBI ETF, is trading significantly higher today, driven by a positive outlook from industry bellwether Thermo...
🔴 XBI is trading 3.05% down today following pelacarsen Phase 3 failure
XBI is trading 3.05% down now at $152.79 as biotechnology shares weaken broadly amid pressure from the pelacarsen Phase 3 failure. - Pelacarsen missed its...
Biotech Sector Gains on Patent News and Continued Positive Momentum
The biotech sector, as measured by the XBI ETF, is trading significantly higher today, led by a more than 35% surge in Purple Biotech (PPBT) shares after the...
Biotech Sector Declines Amid Broad Market Sell-Off
The biotechnology sector, as measured by the XBI ETF, experienced a significant downturn of -4.24% during the regular trading session. This decline coincided...
🔴 XBI is trading 3.07% down today amid concern over a hawkish interest-rate stance
XBI is trading 3.07% down now at $163.06 as investors sell biotech and other high-risk growth assets amid concern that Federal Reserve Chair Kevin Warsh’s...
🟢 XBI is trading 3% up today as biotech shares extend recent momentum
XBI is trading 3.02% up now at $169.13 as biotech shares extend recent momentum amid positive sector sentiment. - The broader market is also modestly higher...
Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
The biotech sector, represented by the XBI ETF, is trading higher today, influenced by a general market upswing ahead of key inflation data and major tech...
Biotech Sector Continues Upward Trend on Strong Momentum
The biotechnology sector, as measured by the XBI ETF, is extending its recent gains, building on strong positive momentum from earlier in the week. This rally...
🔴 XBI is trading 3.4% down today after investors took profits following Moderna’s surge
XBI is trading 3.4% down at $163.72 as investors appear to take profits following Moderna’s dramatic cancer-vaccine-driven surge. - Edesa Biotech’s $25...
Biotech Sector Cools Off After Moderna-Sparked Rally
The biotech sector is experiencing a pullback after a significant surge the previous day, which was ignited by positive cancer vaccine trial results from...
🟢 XBI is trading 4% up today after positive Moderna-Merck melanoma-vaccine results
XBI is trading 3.99% up now at $167.26 after positive Phase 3 melanoma-vaccine results from Moderna and Merck. - Personalized mRNA treatment met its primary...
Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
The biotech sector, proxied by the XBI ETF, is trading significantly higher today following a major positive catalyst from industry leader Moderna. The company...
Biotech Sector Surges on Landmark Cancer Therapy Trial Success from Merck and Moderna
The biotechnology sector, as measured by the XBI ETF, is trading sharply higher in the pre-market session, driven by positive, high-profile clinical trial...
Biotech Sector Rallies on Argenx-Forte M&A Deal
The biotech sector is trading higher, with the XBI ETF up over 2%, driven by news of a significant acquisition. Argenx announced a tender offer to purchase...
🟢 XBI is trading 3.1% up today on biotech earnings strength and broader risk-on rally
XBI is trading 3.1% up today at $151.83, benefiting from a strong biotech sector rally and broader risk-on sentiment across U.S. equities. • Biotech names are...
Biotech Sector Rallies on Strong Earnings and Positive Market Sentiment
The biotechnology sector, as measured by the XBI ETF, is trading higher today, influenced by a combination of positive company-specific news and a broader...
🔴 XBI is trading 3.5% down today amid a sector-wide risk-off shift
XBI is trading 3.5% down at $146.14 amid a sharp biotech pullback and a sector-wide risk-off shift. • The biotechnology group is down over 3% without a single...
Biotech Sector Declines Without A Clear Catalyst
The biotechnology sector, as measured by the XBI ETF, is down over 3% in the current trading session without a clear, identifiable catalyst. While there was...